Fulcrum Equity Management Abb Vie Inc. Transaction History

Fulcrum Equity Management

$115 Million
Q3 2024

A detailed history of Fulcrum Equity Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Fulcrum Equity Management holds 7,205 shares of ABBV stock, worth $1.27 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares

7,205

Previous 8,067 10.69%

Holding current value

$1.27 Million

Previous $1.38 Million 2.82%

% of portfolio

1.24%

Previous 1.28%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	SELL	$163.84 - $199.33 $141,230 - $171,822	-862 Reduced 10.69%	7,205 $1.42 Million
Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $200,453 - $234,084	1,295 Added 19.12%	8,067 $1.38 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $297,265 - $338,706	1,860 Added 37.87%	6,772 $1.23 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $17,062 - $19,216	124 Added 2.59%	4,912 $761,000
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $216,415 - $250,533	1,620 Added 51.14%	4,788 $713,000
Q2 2023 Jul 07, 2023	BUY	$132.51 - $164.9 $5,962 - $7,420	45 Added 1.44%	3,168 $426,000
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $223,711 - $257,637	1,547 Added 98.16%	3,123 $497,000
Q4 2022 Jul 07, 2023	SELL	$138.31 - $165.87 $220,189 - $264,065	-1,592 Reduced 50.25%	1,576 $254,000
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $217,976 - $261,411	1,576 New	1,576 $0
Q1 2022 Apr 15, 2022	SELL	$131.98 - $163.75 $310,416 - $385,140	-2,352 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $5,693 - $7,204	-53 Reduced 2.2%	2,352 $318,000
Q3 2021 Jan 25, 2022	BUY	$106.4 - $120.78 $2,128 - $2,415	20 Added 0.84%	2,405 $259,000
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $20,095 - $22,387	191 Added 8.71%	2,385 $269,000
Q1 2021 Apr 05, 2021	BUY	$102.3 - $112.62 $16,674 - $18,357	163 Added 8.03%	2,194 $237,000
Q4 2020 Feb 22, 2021	BUY	$80.49 - $108.67 $163,475 - $220,708	2,031 New	2,031 $218,000
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $342,866 - $402,412	-3,991 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $53,633 - $71,769	731 Added 22.42%	3,991 $392,000
Q1 2020 Apr 01, 2020	SELL	$64.5 - $97.79 $104,683 - $158,713	-1,623 Reduced 33.24%	3,260 $248,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $17,022 - $21,299	-236 Reduced 4.61%	4,883 $432,000
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $12,092 - $14,538	192 Added 3.9%	5,119 $388,000
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $88,957 - $113,708	1,354 Added 37.9%	4,927 $323,000
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $2,468 - $2,905	32 Added 0.9%	3,573 $288,000
Q4 2018 Mar 05, 2019	BUY	$77.85 - $96.01 $275,666 - $339,971	3,541 New	3,541 $326,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Equity Management with notifications on news.

Account

Fulcrum Equity Management Abb Vie Inc. Transaction History